Physician profile
Michael Terrani
NPI 1841377231
$26,695.67
in general payments reported to CMS, 2019-2025
18 companies · $26K in 2025
The $26K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $386 · 2020: $30.33 · 2021: $14.67 · 2023: $437 · 2024: $76.54 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $26K · Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $25,690.69 |
| Food and Beverage | $573.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $25,705.76 | 2019-2025 | Olympus |
| Abbvie INC. | $187.35 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Daiichi Sankyo INC. | $165.34 | 2023-2024 | Injectafer |
| Mayne Pharma Commercial LLC | $137.64 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $113.69 | 2019-2021 | |
| Shield Therapeutics INC | $87.90 | 2023-2025 | Accrufer |
| Mylan Pharmaceuticals INC. | $48.51 | 2019 | |
| Organon LLC | $31.45 | 2023 | Nexplanon |
| Novo Nordisk INC | $31.21 | 2019-2020 | |
| Coopersurgical, INC. | $26.44 | 2023 | Paragard T 380a |
| Hologic Sales and Service, LLC | $26.33 | 2019 | |
| Biogen, INC. | $26.27 | 2024 | |
| Smith+Nephew, INC. | $25.23 | 2019 | |
| Myriad Women'S Health, INC. | $22.43 | 2023 | Myrisk |
| Agile Therapeutics, INC. | $18.75 | 2023 | Twirla |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $16.02 | 2019 | |
| Avion Pharmaceuticals | $14.36 | 2019 | |
| Dysis Medical, INC. | $10.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Terrani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.